Annual SGA
$5.72 M
-$1.42 M-19.85%
December 31, 2023
Summary
- As of February 26, 2025, SLRX annual SGA is $5.72 million, with the most recent change of -$1.42 million (-19.85%) on December 31, 2023.
- During the last 3 years, SLRX annual SGA has fallen by -$384.60 thousand (-6.30%).
- SLRX annual SGA is now -71.19% below its all-time high of $19.86 million, reached on December 31, 2016.
Performance
SLRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$869.20 K
-$383.90 K-30.64%
September 30, 2024
Summary
- As of February 26, 2025, SLRX quarterly SGA is $869.20 thousand, with the most recent change of -$383.90 thousand (-30.64%) on September 30, 2024.
- Over the past year, SLRX quarterly SGA has stayed the same.
- SLRX quarterly SGA is now -84.04% below its all-time high of $5.45 million, reached on September 30, 2016.
Performance
SLRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$314.36 M
-$4.99 M-1.61%
September 30, 2024
Summary
- As of February 26, 2025, SLRX TTM SGA is -$314.36 million, with the most recent change of -$4.99 million (-1.61%) on September 30, 2024.
- Over the past year, SLRX TTM SGA has dropped by -$318.92 million (-6991.40%).
- SLRX TTM SGA is now -7264.09% below its all-time high of -$4.27 million.
Performance
SLRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SLRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | 0.0% | -6991.4% |
| 3 y3 years | -6.3% | -46.3% | -4630.4% |
| 5 y5 years | -45.9% | -46.3% | -4630.4% |
SLRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | at low | -52.7% | at low | -196.8% | at low |
| 5 y | 5-year | -25.8% | at low | -53.2% | at low | -500.2% | at low |
| alltime | all time | -71.2% | at low | -84.0% | at low | -7264.1% | +41.3% |
Salarius Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $869.20 K(-30.6%) | $4.56 M(-12.1%) |
| Jun 2024 | - | $1.25 M(-18.0%) | $5.19 M(-6.6%) |
| Mar 2024 | - | $1.53 M(+67.8%) | $5.55 M(-2.9%) |
| Dec 2023 | $5.72 M(-19.9%) | $910.70 K(-39.1%) | $5.72 M(-13.4%) |
| Sep 2023 | - | $1.50 M(-7.6%) | $6.60 M(-4.8%) |
| Jun 2023 | - | $1.62 M(-4.5%) | $6.94 M(-3.0%) |
| Mar 2023 | - | $1.70 M(-5.4%) | $7.16 M(+0.2%) |
| Dec 2022 | $7.14 M(+16.9%) | $1.79 M(-2.2%) | $7.14 M(+5.0%) |
| Sep 2022 | - | $1.83 M(-0.2%) | $6.80 M(+1.5%) |
| Jun 2022 | - | $1.84 M(+9.5%) | $6.69 M(+3.8%) |
| Mar 2022 | - | $1.68 M(+15.8%) | $6.45 M(+5.7%) |
| Dec 2021 | $6.10 M(-0.0%) | $1.45 M(-16.3%) | $6.10 M(+4.0%) |
| Sep 2021 | - | $1.73 M(+8.7%) | $5.87 M(+7.3%) |
| Jun 2021 | - | $1.59 M(+19.4%) | $5.47 M(-2.0%) |
| Mar 2021 | - | $1.33 M(+9.9%) | $5.58 M(-8.6%) |
| Dec 2020 | $6.11 M(-20.8%) | $1.21 M(-9.0%) | $6.11 M(-8.2%) |
| Sep 2020 | - | $1.33 M(-21.6%) | $6.65 M(-24.5%) |
| Jun 2020 | - | $1.70 M(-8.5%) | $8.81 M(+9.1%) |
| Mar 2020 | - | $1.86 M(+5.6%) | $8.08 M(-5.2%) |
| Dec 2019 | $7.71 M | $1.76 M(-49.6%) | $8.52 M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.49 M(+261.1%) | $8.68 M(+21.5%) |
| Jun 2019 | - | $967.70 K(-57.9%) | $7.15 M(-22.1%) |
| Mar 2019 | - | $2.30 M(+19.7%) | $9.18 M(-13.2%) |
| Dec 2018 | $10.57 M(-42.9%) | $1.92 M(-2.0%) | $10.57 M(-16.3%) |
| Sep 2018 | - | $1.96 M(-34.6%) | $12.63 M(-19.1%) |
| Jun 2018 | - | $2.99 M(-19.0%) | $15.61 M(-11.3%) |
| Mar 2018 | - | $3.70 M(-7.2%) | $17.61 M(-4.8%) |
| Dec 2017 | $18.50 M(-6.8%) | $3.98 M(-19.3%) | $18.50 M(+0.3%) |
| Sep 2017 | - | $4.93 M(-1.1%) | $18.44 M(-2.7%) |
| Jun 2017 | - | $4.99 M(+8.6%) | $18.95 M(-2.0%) |
| Mar 2017 | - | $4.59 M(+17.3%) | $19.34 M(-2.6%) |
| Dec 2016 | $19.86 M(+20.6%) | $3.92 M(-28.1%) | $19.86 M(-3.4%) |
| Sep 2016 | - | $5.45 M(+1.3%) | $20.56 M(+3.7%) |
| Jun 2016 | - | $5.38 M(+5.2%) | $19.83 M(+8.0%) |
| Mar 2016 | - | $5.11 M(+10.6%) | $18.36 M(+11.5%) |
| Dec 2015 | $16.46 M | $4.62 M(-2.1%) | $16.46 M(+39.0%) |
| Sep 2015 | - | $4.72 M(+20.9%) | $11.84 M(+44.3%) |
| Jun 2015 | - | $3.90 M(+21.4%) | $8.20 M(+52.1%) |
| Mar 2015 | - | $3.22 M(+196.6%) | $5.39 M(+147.7%) |
| Sep 2014 | - | $1.08 M(-0.8%) | $2.18 M(+99.2%) |
| Jun 2014 | - | $1.09 M | $1.09 M |
FAQ
- What is Salarius Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual SGA year-on-year change?
- What is Salarius Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly SGA year-on-year change?
- What is Salarius Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM SGA year-on-year change?
What is Salarius Pharmaceuticals annual SGA?
The current annual SGA of SLRX is $5.72 M
What is the all time high annual SGA for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual SGA is $19.86 M
What is Salarius Pharmaceuticals annual SGA year-on-year change?
Over the past year, SLRX annual SGA has changed by -$1.42 M (-19.85%)
What is Salarius Pharmaceuticals quarterly SGA?
The current quarterly SGA of SLRX is $869.20 K
What is the all time high quarterly SGA for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly SGA is $5.45 M
What is Salarius Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, SLRX quarterly SGA has changed by $0.00 (0.00%)
What is Salarius Pharmaceuticals TTM SGA?
The current TTM SGA of SLRX is -$314.36 M
What is the all time high TTM SGA for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM SGA is -$4.27 M
What is Salarius Pharmaceuticals TTM SGA year-on-year change?
Over the past year, SLRX TTM SGA has changed by -$318.92 M (-6991.40%)